Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Veterinary Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102898375A details a Pd/C hydrogenation method for high-purity veterinary intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Novel preparation method for Baquiloprim improves yield and reduces cost for veterinary drug manufacturing supply chains significantly. Reliable source for high purity intermediates.
Patent CN108929253B details a high-yield route for pleuromutilin compounds, offering cost-effective antibiotic intermediate manufacturing solutions.
Patent CN115304472A reveals a cost-effective 5-step route for Fluralaner intermediates. Discover how this non-cyanide process ensures high purity and supply stability.
Patent CN104277050B details a novel crystallization method for Moxidectin. This process enhances purity and reduces purification complexity for supply chains.
Patent CN113322291A details an enzymatic route for high-purity chiral amino alcohols, offering cost-effective solutions for veterinary antibiotic manufacturing.
Patent CN104017001A reveals improved moxidectin synthesis. Reduces cost and improves supply chain reliability for veterinary drug manufacturers.
Patent CN104098521B reveals improved diclazuril preparation with higher purity and yield, offering cost reduction in veterinary drug manufacturing and reliable supply chain solutions.
Novel synthetic route for flunixin meglumine intermediate using p-toluenesulfonic acid. High yield, cost-effective, scalable process for veterinary pharmaceutical manufacturing.
Novel 6-step synthesis from epoxy-pregnane. High yield, industrial scale. Cost-effective veterinary hormone intermediate manufacturing.
Patent CN106380452A reveals solvent reduction technology for oxfendazole. Enhances supply chain reliability and cost reduction in veterinary drugs manufacturing.
Patent CN102070497B reveals a novel four-step synthesis for florfenicol. This method offers mild conditions and high yields, ensuring cost reduction and supply chain reliability for global buyers.
Patent CN107176948B details a safer pimobendan route eliminating toxic reagents. This offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Novel purification protocol enhances tildipirosin purity and yield while reducing costs for veterinary pharmaceutical supply chains globally ensuring stable availability.
Patent CN101921211A details a novel crystallization method for oxytetracycline. This process enhances purity and yield while simplifying supply chain logistics for veterinary manufacturers.
Patent CN101245049A offers improved Palbendazole synthesis with reduced waste and cost for veterinary supply chains.
Patent CN115785179B reveals a cost-effective oxidation method for high-purity siramectin. Enhance supply chain reliability and reduce manufacturing costs with scalable veterinary drug intermediates.
Novel diazotization method reduces costs for Afoxolaner intermediates. Mild conditions, high yield, scalable production for global supply chains.
Patent CN105254648B reveals optimized cephalosporin route reducing steps and improving scalability for reliable supply chains globally. This method ensures high purity veterinary drug intermediates with simplified operational conditions for industrial partners.
Patent CN103288764A reveals water soluble quinoxaline precursor enhancing veterinary drug safety and supply chain reliability for global procurement teams.